{
    "nct_id": "NCT05592665",
    "official_title": "PRO-VISION: Patient Reported Outcomes-Based Monitoring of VEGF-Inhibitor Side Effects in ONcology",
    "inclusion_criteria": "* Adult patients aged 18 years or older\n* Histologically confirmed renal cell carcinoma requiring treatment with VEGF TKI.\n* Patients may be receiving other concurrent cancer-directed therapy such as immune checkpoint inhibitors.\n* English or Spanish speaking\n* Ability to complete PRO surveys (i.e. ability to read/write or access to telephone or internet)\n* Willing and able to meet all study requirements\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "All subjects meeting any of the exclusion criteria at baseline will be excluded from study participation.\n\nâ€¢ Inability for any reason to complete PRO surveys",
    "miscellaneous_criteria": ""
}